ChIP Kit Magnetic - One Step (ab156907)
Key features and details
- Assay time: 5 hr
Overview
-
Product name
ChIP Kit Magnetic - One Step
See all ChIP Kit kits -
Assay time
5h 00m -
Product overview
Abcam's ChIP Kit Magnetic - One Step (ab156907) is a complete set of optimized buffers and reagents to carry out a successful chromatin immunoprecipitation for the selective enrichment of a chromatin fraction containing specific DNA sequences from isolated chromatin, in order to investigate the interaction between proteins and DNA in a cell. For best result, we recommend the use of Chromatin Extraction Kit (ab117152) for sample preparation.
Protein-DNA interactions play a critical role for cellular functions such as signal transduction, gene transcription and epigenetic silencing. In mammalian cells, interactions between the DNA-binding proteins and cognate promoter sequences are primary determinants in establishing spatial and temporal expression patterns of gene that affect homeostasis, development, and adaptation.
-
Notes
Primers
The GAPDH primers provided with the kit are for the human sequence. If using the kit with a difference species, GAPDH primers for that species will need to be acquired.
ChIP assay products and guides
Find more ChIP assay / chromatin immunoprecipitation resources and products, ChIP antibody products, and other ChIP assay kits and related reagents.
-
Tested applications
Suitable for: ChIPmore details
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 48 tests 96 tests 10X Wash Buffer 1 x 10ml 1 x 20ml 8-Well Strip Caps 1 x 12 units 1 x 24 units 96-Well PCR Plate 1 x 2 units 1 x 2 units Anti-RNA Polymerase II (1 mg/mL) 1 x 8µl 1 x 16µl ChIP Buffer 1 x 6ml 1 x 12ml DNA Release Buffer 1 x 14ml 1 x 28ml GAPDH Primer - Forward (20 µM) 1 x 8µl 1 x 16µl GAPDH Primer - Reverse (20 µM) 1 x 8µl 1 x 16µl Magnetic Beads 1 x 220µl 1 x 450µl Non-Immune IgG (1 mg/mL) 1 x 10µl 1 x 20µl Proteinase K (10 mg/mL) 1 x 55µl 1 x 110µl -
Research areas
Associated products
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab156907 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ChIP |
Use at an assay dependent concentration.
The GAPDH primers provided with the kit are for the human sequence. If using the kit with a different species, GAPDH primers for that species will need to be acquired. |
Notes |
---|
ChIP
Use at an assay dependent concentration. The GAPDH primers provided with the kit are for the human sequence. If using the kit with a different species, GAPDH primers for that species will need to be acquired. |
Images
-
The data shows the analysis of enrichment of RNA polymerase II in GAPDH and MLH1 promoters by Abcam's ChIP Kit Magnetic - One Step (ab156907) with chromatin extract prepared from formaldehyde fixed colon cancer cells. Captured DNA was used for analyzing levels of RNA polymerase II enriched in the GAPDH and MLH1 promoters.
Datasheets and documents
-
SDS download
-
Datasheet download
References (15)
ab156907 has been referenced in 15 publications.
- Jin X et al. Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma. Oncogene 41:538-549 (2022). PubMed: 34785774
- Liu W et al. The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC. Int J Biol Sci 18:2132-2145 (2022). PubMed: 35342353
- Li W et al. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. J Exp Clin Cancer Res 41:250 (2022). PubMed: 35974388
- Sun Y et al. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer. Cell Death Dis 12:878 (2021). PubMed: 34564701
- Su W et al. Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. J Exp Clin Cancer Res 40:88 (2021). PubMed: 33648545